Collegium Pharmaceutical: Q1 Earnings Snapshot
Collegium Pharmaceutical Inc. (COLL) on Thursday reported a loss of $17.4 million in its first quarter
By AP News
Published - May 04, 2023, 04:48 PM ET
Last Updated - Apr 05, 2024, 02:16 PM EDT
STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported a loss of $17.4 million in its first quarter.
The Stoughton, Massachusetts-based company said it had a loss of 51 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.32 per share.
The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of $1.32 per share.
The specialty pharmaceutical company posted revenue of $144.8 million in the period, which topped Street forecasts. Four analysts surveyed by Zacks expected $139.1 million.
